These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16316670

  • 1. Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.
    Yao BB, Witte DG, Miller TR, Carr TL, Kang CH, Cassar S, Faghih R, Bennani YL, Surber BW, Hancock AA, Esbenshade TA.
    Neuropharmacology; 2006 Mar; 50(4):468-78. PubMed ID: 16316670
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
    Zhang G, Huang N, Li YW, Qi X, Marshall AP, Yan XX, Hill G, Rominger C, Prakash SR, Bakthavatchalam R, Rominger DH, Gilligan PJ, Zaczek R.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):57-69. PubMed ID: 12649353
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):933-45. PubMed ID: 15294456
    [Abstract] [Full Text] [Related]

  • 13. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
    Igel P, Schnell D, Bernhardt G, Seifert R, Buschauer A.
    ChemMedChem; 2009 Feb 01; 4(2):225-31. PubMed ID: 19101971
    [Abstract] [Full Text] [Related]

  • 14. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
    Klotz KN, Falgner N, Kachler S, Lambertucci C, Vittori S, Volpini R, Cristalli G.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):14-8. PubMed ID: 17126322
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K, Cumming P, Minuzzi L.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):75-9. PubMed ID: 17350614
    [Abstract] [Full Text] [Related]

  • 16. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL, Sobotka-Briner C, Ding M, Powell ME, Jiang Q, Hill G, Heys JR, Elmore CS, Pierson ME, Mrzljak L.
    J Pharmacol Exp Ther; 2009 Jul 14; 330(1):342-51. PubMed ID: 19401496
    [Abstract] [Full Text] [Related]

  • 17. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.
    Stark H, Purand K, Hüls A, Ligneau X, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1996 Mar 15; 39(6):1220-6. PubMed ID: 8632428
    [Abstract] [Full Text] [Related]

  • 18. Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?
    Leurs R, Kathmann M, Vollinga RC, Menge WM, Schlicker E, Timmerman H.
    J Pharmacol Exp Ther; 1996 Mar 15; 276(3):1009-15. PubMed ID: 8786529
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW, Harrell CM, Reiss DR, Murphy KL, Chang RS, Hess JF, Miller PJ, O'Malley SS, Hey PJ, Kunapuli P, Su DS, Markowitz MK, Wallace MA, Raab CE, Jones AN, Dean DC, Pettibone DJ, Freidinger RM, Bock MG.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):77-84. PubMed ID: 15363953
    [Abstract] [Full Text] [Related]

  • 20. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
    Garduño-Torres B, Arias-Montaño JA.
    Synapse; 2006 Aug 19; 60(2):165-71. PubMed ID: 16715497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.